Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI

Edward A. Copelan, Betty K. Hamilton, Belinda Avalos, Kwang W. Ahn, Brian J. Bolwell, Xiaochun Zhu, Mahmoud Aljurf, Koen Van Besien, Christopher Bredeson, Jean Yves Cahn, Luciano J. Costa, Marcos De Lima, Robert P. Gale, Gregory A. Hale, Joerg Halter, Mehdi Hamadani, Yoshihiro Inamoto, Rammurti T. Kamble, Mark R. Litzow, Alison W. LorenDavid I. Marks, Eduardo Olavarria, Vivek Roy, Mitchell Sabloff, Bipin N. Savani, Matthew Seftel, Harry C. Schouten, Celalettin Ustun, Edmund K. Waller, Daniel J. Weisdorf, Baldeep Wirk, Mary M. Horowitz, Mukta Arora, Jeff Szer, Jorge Cortes, Matt E. Kalaycio, Richard T. Maziarz, Wael Saber

Research output: Contribution to journalArticlepeer-review

118 Scopus citations

Fingerprint

Dive into the research topics of 'Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds